AI tool for diagnosing breast phyllodes tumors
Part of Cancer clinical trials.
This trial uses an artificial intelligence system to help doctors more accurately diagnose and predict the outcome of breast phyllodes tumors, which are rare breast growths. It aims to improve how these tumors are identified and managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a phyllodes tumor of the breast.
- Your medical images (like ultrasound or mammogram) are clear and not blurry or distorted.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an artificial intelligence (AI) tool can help doctors plan radiation therapy more precisely for breast cancer. It aims to make treatment safer and more effective by using AI to outline the area to be treated.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This trial tests a human-AI system to help diagnose breast cancer that contains a large area of abnormal cells called ductal carcinoma in situ (DCIS). The goal is to see if the AI can help pathologists more accurately identify DCIS in tumor samples. This may be an option if you have been diagnosed with DCIS (with or without invasive cancer) and your tumor is larger than 2 cm.
This study tests an artificial intelligence (AI) helper that assists doctors in managing thyroid cancer. It aims to see if the tool can improve care for patients like you.
This trial uses an artificial intelligence model to improve the accuracy of diagnosing early-stage breast cancer. The AI analyzes breast mass pathology results to help doctors make better decisions.
Hear when a new Multiomics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.